Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Catherine Callister

Concepts (75)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Buprenorphine
3
2024
134
1.480
Why?
Opioid-Related Disorders
3
2024
413
1.140
Why?
Opiate Substitution Treatment
2
2024
98
0.870
Why?
Internal Medicine
2
2024
211
0.810
Why?
Hospitalists
2
2023
174
0.790
Why?
Internship and Residency
3
2024
926
0.680
Why?
Organization and Administration
1
2019
8
0.670
Why?
Qualitative Research
2
2021
936
0.510
Why?
Patient Discharge
1
2019
772
0.440
Why?
Caregivers
1
2019
717
0.420
Why?
Referral and Consultation
3
2022
635
0.310
Why?
Analgesics, Opioid
3
2024
771
0.280
Why?
Methadone
2
2024
77
0.260
Why?
Home Care Services
2
2019
223
0.210
Why?
Hospital Medicine
1
2023
82
0.200
Why?
Octamer Transcription Factor-3
2
2015
16
0.200
Why?
Social Workers
1
2021
32
0.190
Why?
Subacute Care
1
2021
71
0.170
Why?
Pharmacists
1
2021
233
0.160
Why?
Health Knowledge, Attitudes, Practice
2
2024
1183
0.150
Why?
Professional-Patient Relations
1
2019
141
0.150
Why?
Clinical Competence
1
2024
893
0.140
Why?
Attitude of Health Personnel
1
2024
975
0.140
Why?
Cross-Sectional Studies
2
2024
4410
0.130
Why?
Pluripotent Stem Cells
1
2015
63
0.110
Why?
Substance-Related Disorders
1
2021
947
0.110
Why?
Nucleosomes
1
2015
123
0.110
Why?
Surveys and Questionnaires
1
2024
4623
0.100
Why?
Humans
11
2024
114689
0.100
Why?
Thrombophlebitis
1
1991
8
0.100
Why?
Geriatric Assessment
1
2012
176
0.090
Why?
DNA Methylation
1
2015
495
0.090
Why?
Heparin
1
1991
224
0.090
Why?
Psychomotor Performance
1
2012
280
0.090
Why?
Neuropsychological Tests
1
2012
927
0.080
Why?
Regulatory Elements, Transcriptional
1
2008
16
0.070
Why?
Electrophoretic Mobility Shift Assay
1
2008
72
0.070
Why?
Hospitals
2
2022
581
0.070
Why?
Oligonucleotide Array Sequence Analysis
1
2008
740
0.060
Why?
Cognition
1
2012
989
0.060
Why?
Adult
2
2024
30550
0.060
Why?
Chromatin Immunoprecipitation
2
2015
128
0.050
Why?
Male
3
2024
55599
0.050
Why?
Embryonic Stem Cells
2
2015
106
0.050
Why?
Academic Medical Centers
1
2023
411
0.050
Why?
Social Stigma
1
2021
87
0.040
Why?
Female
2
2024
59511
0.040
Why?
Patient Transfer
1
2021
143
0.040
Why?
Promoter Regions, Genetic
2
2015
1131
0.040
Why?
United States
2
2023
12183
0.030
Why?
DNA (Cytosine-5-)-Methyltransferases
1
2015
26
0.030
Why?
Regulatory Sequences, Nucleic Acid
1
2015
81
0.030
Why?
Jumonji Domain-Containing Histone Demethylases
1
2015
59
0.030
Why?
Fibula
1
1991
41
0.020
Why?
Homeodomain Proteins
1
2015
463
0.020
Why?
Infusions, Intravenous
1
1991
371
0.020
Why?
Fibroblasts
1
2015
838
0.020
Why?
Histones
1
2015
535
0.020
Why?
Oligonucleotide Probes
1
2008
54
0.020
Why?
DNA-Binding Proteins
1
2015
1314
0.020
Why?
Cell Differentiation
1
2015
1701
0.020
Why?
Predictive Value of Tests
1
2012
1796
0.020
Why?
Cells, Cultured
1
2015
3886
0.020
Why?
Mice
2
2015
14869
0.020
Why?
Binding Sites
1
2008
1168
0.010
Why?
Genomics
1
2008
635
0.010
Why?
Aging
1
2012
1618
0.010
Why?
Cell Line
1
2008
2637
0.010
Why?
Time Factors
1
2012
6116
0.010
Why?
Child
1
2021
18415
0.010
Why?
Aged, 80 and over
1
2012
6347
0.010
Why?
Prospective Studies
1
2012
6220
0.010
Why?
DNA
1
2008
1352
0.010
Why?
Animals
2
2015
31706
0.010
Why?
Aged
1
2012
19074
0.010
Why?
Callister's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)